Skoči na glavni sadržaj

Sažetak sa skupa

https://doi.org/10.15836/ccar2023.78

Functional testing in coronary bypass grafts

Sandra Šarić orcid id orcid.org/0000-0002-7487-1189 ; Clinical Hospital Center Osijek, Osijek, Croatia
Marin Vučković ; Clinical Hospital Center Osijek, Osijek, Croatia
Petra Zebić Mihić orcid id orcid.org/0000-0003-1302-6165 ; Clinical Hospital Center Osijek, Osijek, Croatia


Puni tekst: engleski pdf 143 Kb

str. 78-78

preuzimanja: 172

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

functional testing; coronary bypass graft; left internal mammary artery

Hrčak ID:

295959

URI

https://hrcak.srce.hr/295959

Datum izdavanja:

16.3.2023.

Posjeta: 527 *



This paper offers options in defining physiological severity of graft stenosis and resolving ambiguous anatomic issues with functional testing of bypass grafts, for accomplishing successful percutaneous coronary interventions. Ostial lesion position and often ambiguous separation of left internal mammary artery (LIMA), from subclavian artery demands meticulous angiographical or functional assessment and accurate stent positioning. In European Society of Cardiology (ESC) guidelines invasive functional testing is nowadays classed with IA level of evidence for percutaneous coronary revascularization, because it provides reduction in clinical outcome and lowers procedural costs. But these data are completely cultivated through native epicardial arteries. Relatively small trial from Serafino et al (1) found that fractional flow reserve (FFR) could be available in invasive functional testing of graft conduits. This trial tested outcomes after FFR versus angio-guided percutaneous coronary intervention (PCI) in 233 patients and found better clinical and economical outcomes with significant major adverse cardiovascular events (MACE) reduction. Newer methods like iFR® (instantaneous wave-free ratio) offers slightly different approach measuring a part of diastolic cardiac cycle, that is „wave-free“ with minimized microvascular resistance. iFR physiology testing in early trials showed non inferiority to FFR in native coronary artery. (2) While FFR cutting point was 0.8, iFR cutting point was slightly elevated - 0.89. IFR was never tested in arterial or venous graft conduits through randomized trials. The important question that arises is the question of the position of IFR wire when measuring the stenosis in LIMA. Whether it is necessary to zero the wire in the area of the subclavian artery or the root of the aorta. Nevertheless, based on previously knowledge and experience we functionally tested several bypass grafts stenosis with iFR, and result was clinically utilized in practice.

LITERATURE

1 

Di Serafino L, De Bruyne B, Mangiacapra F, Bartunek J, Agostoni P, Vanderheyden M, et al. Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. Am Heart J. 2013 July;166(1):110–8. https://doi.org/10.1016/j.ahj.2013.04.007 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/23816029

2 

Götberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, et al. iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813–23. https://doi.org/10.1056/NEJMoa1616540 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/28317438


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.